Source: WebMD
Posted: November 9, 2006
Summary:
Early lab tests on mice conducted by researchers at the Universty of Louisville have shown that embryonic stem cells could potentially be used to create a cancer vaccine. The embryonic stem cells were taken from mouse embryos to make two experimental vaccines against mouse lung cancer. One of the vaccines contained only embryonic stem cells. The other vaccine contained embryonic stem cells plus a growth factor to boost immune response. This strategy might eventually be able to innoculate humans who have a high risk for development of cancer.
No comments:
Post a Comment